Healthcare

FDA greenlights Pfizer vaccine boosters for 16- and 17-year-olds

By Cassidy Morrison
Published December 9, 2021 4:56pm ET
Add Washington Examiner on Google
FDA greenlights Pfizer vaccine boosters for 16- and 17-year-olds
The Food and Drug Administration authorized Pfizer booster shots for 16- and 17-year-olds on Thursday, clearing a hurdle for about 2.6 million more people to get a second dose of the COVID-19 vaccine. OMICRON FEARS BOOSTING VACCINATIONS “Since we first authorized the vaccine, new evidence indicates that vaccine effectiveness against COVID-19 is waning after the […]

The Food and Drug Administration authorized Pfizer booster shots for 16- and 17-year-olds on Thursday, clearing a hurdle for about 2.6 million more people to get a second dose of the COVID-19 vaccine.

OMICRON FEARS BOOSTING VACCINATIONS

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

COVID-19 FDA Pfizer Pharmaceutical Industry Vaccines